These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34372774)

  • 21. Biphasic effect of alcohol intake on the development of fatty liver disease.
    Takahashi H; Ono M; Hyogo H; Tsuji C; Kitajima Y; Ono N; Eguchi T; Fujimoto K; Chayama K; Saibara T; Anzai K; Eguchi Y
    J Gastroenterol; 2015 Nov; 50(11):1114-23. PubMed ID: 25733100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
    Hamaguchi M; Kojima T; Takeda N; Nakagawa T; Taniguchi H; Fujii K; Omatsu T; Nakajima T; Sarui H; Shimazaki M; Kato T; Okuda J; Ida K
    Ann Intern Med; 2005 Nov; 143(10):722-8. PubMed ID: 16287793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases.
    Chang Y; Cho J; Cho YK; Cho A; Hong YS; Zhao D; Ahn J; Sohn CI; Shin H; Guallar E; Ryu S
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):205-215.e7. PubMed ID: 31085337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity.
    Cho IY; Chang Y; Sung E; Kang JH; Wild SH; Byrne CD; Shin H; Ryu S
    Epidemiol Psychiatr Sci; 2021 Mar; 30():e23. PubMed ID: 33706839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
    Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
    Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study.
    Niriella MA; Kasturiratna A; Beddage T; Ediriweera DS; De Silva ST; Perera KR; Subasinghe CE; Kodisinghe SK; Piyaratna TC; Rishikesawan V; Dassanayaka AS; De Silva AP; Pathmeswaran A; Wickramasinghe AR; Kato N; Janaka de Silva H
    PLoS One; 2019; 14(10):e0224474. PubMed ID: 31661524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiological similarities and synergisms in alcoholic and non-alcoholic steatohepatitis.
    Hellerbrand C
    Dig Dis; 2010; 28(6):783-91. PubMed ID: 21525763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies.
    Åberg F; Färkkilä M; Männistö V
    Alcohol Clin Exp Res; 2020 Feb; 44(2):384-403. PubMed ID: 31854001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population.
    Lee SW; Lee TY; Yang SS; Peng YC; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):176-180. PubMed ID: 28381382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
    Baranova A; Tran TP; Birerdinc A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Apr; 33(7):801-14. PubMed ID: 21251033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short sleep duration is a risk of incident nonalcoholic fatty liver disease: a population-based longitudinal study.
    Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    J Gastrointestin Liver Dis; 2019 Mar; 28(1):73-81. PubMed ID: 30851175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
    Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J
    Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
    Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study.
    Okamoto M; Miyake T; Kitai K; Furukawa S; Yamamoto S; Senba H; Kanzaki S; Deguchi A; Koizumi M; Ishihara T; Miyaoka H; Yoshida O; Hirooka M; Kumagi T; Abe M; Matsuura B; Hiasa Y
    PLoS One; 2018; 13(4):e0195147. PubMed ID: 29664906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population.
    Åberg F; Helenius-Hietala J; Puukka P; Färkkilä M; Jula A
    Hepatology; 2018 Jun; 67(6):2141-2149. PubMed ID: 29164643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors for pure steatosis in alcoholic patients.
    Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis.
    Sánchez-Jiménez BA; Brizuela-Alcántara D; Ramos-Ostos MH; Alva-López LF; Uribe-Esquivel M; Chávez-Tapia NC
    Alcohol; 2018 Jun; 69():63-67. PubMed ID: 29660603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental models of metabolic and alcoholic fatty liver disease.
    Buyco DG; Martin J; Jeon S; Hooks R; Lin C; Carr R
    World J Gastroenterol; 2021 Jan; 27(1):1-18. PubMed ID: 33505147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
    Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
    BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.